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Abstract: RT-qPCR is the standard method for studying changes in relative transcript level 
in different experimental and clinical conditions and in different tissues. No validated 
reference genes have been reported for the normalization of transcript level in platelets. 
The very low level of platelet RNA and the elimination of leukocyte contamination 
represented special methodological difficulties. Our aims were to apply a simple technique 
to separate platelets for transcript level studies, and select the most stable reference genes 
for platelets from healthy individuals and from patients with the history of myocardial 
infarction. We developed a simple, straightforward method of platelet separation for  
RNA isolation. Platelet activation was inhibited by using acid-citrate-dextrose for 
anticoagulation and by prostaglandin E1. Leukocyte contamination was eliminated by three 
consecutive centrifugations. Samples prepared by this method were free of leukocytes, 
showed no inhibition in PCR reaction and no RNA degradation. The assay demands low 
blood volume, which complies with the requirements of everyday laboratory routine. 
Seventeen potential reference genes were investigated, but eight of them were excluded 
during optimization. The stability of the remaining genes, EEF2, EAR, ACTB, GAPDH, 
ANAPC5, OAZ1, HDGF, GNAS, and CFL1, were determined by four different descriptive 
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statistics. GAPDH, GNAS, and ACTB were shown to be the most stable genes in platelets 
of healthy individuals, while HDGF, GNAS, and ACTB were the most stable in platelets of 
patients with the history of myocardial infarction. The results confirm that data 
normalization needs assessment of appropriate reference genes for a particular sample set. 
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1. Introduction 
Reverse transcription quantitative real-time PCR (RT-qPCR) is, at present, the most sensitive 
method for the detection and quantitation of low abundance mRNAs [1]. It is crucial to control for 
variation between samples when measuring mRNA expression. One approach is to normalize to total 
RNA. This approach needs a reliable RNA quantification method and fails to take into account the 
variability in reverse transcription and other steps of the measurement [2]. The use of reference genes 
(RGs) as an internal control is the most common approach for data normalization [3]. On the other 
hand, the use of a single internal RG for normalization could lead to relatively large errors [4]. RGs 
used for the quantification of mRNA expression could vary with tissue type as well as with 
physiological, pathological and experimental conditions, and their validation and optimization for 
accurate and reproducible quantitation is essential [5]. Previous reports on platelet mRNA expression 
used conventional RGs [6,7], but details concerning their selection, validation, and investigation of 
stable expression were not provided. 
Circulating platelets contain an exceptionally small amount of megakaryocyte derived mRNA. Low 
mRNA concentration and contamination with leukocytes are two main hindrances of platelet transcript 
level studies. To decrease the volume of whole blood required for single individual transcript level 
studies and to amplify the starting platelet mRNA, different amplification strategies have been used [8]. 
Leukocyte contamination was decreased by filtration and magnetic leukocyte-depletion [8–10]. These 
techniques could not decrease the volume of whole blood required for the measurements to less than 
40 mL. Toyama et al. succeeded in decreasing the required volume to 20 mL, but they did not provide 
firm evidence on efficient removal of leukocytes from platelet suspension (see Supplementary  
Table S1) [11]. The aims of our study were: (1) to find a simple procedure for the separation of 
platelets from other blood cells, (2) to develop a method that requires only low volume of blood for 
mRNA quantification, and (3) to select and validate the most stably expressed mRNAs from a panel of 
seventeen RGs which can be used in RT-qPCR experiments for the normalization of transcript level in 
platelets of healthy individuals and patients with the history of myocardial infarction. The expression 
stability of the RGs was tested by four different approaches described in the literature [4,12–14] using 
RefFinder algorithm [15]. To ensure experimental transparency, accuracy, and repeatability, we 
followed the MIQE guidelines [16]. 
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2. Results 
2.1. Evaluation of RNA Integrity, Contamination and Inhibition 
Amplification of each of the candidate genes was confirmed by the appearance of a single peak in 
the RT-qPCR melting curve analyses. Prior to carrying out RT-qPCR reactions, the integrity of all 
RNA samples was examined using real-time PCR to evaluate the expression of the GAPDH gene [5]. 
RNA integrity was in the acceptable range for all samples. When SPUD amplicons were added to each 
qPCR reaction in equal amount, the reactions demonstrated complete absence of qPCR inhibition. 
White blood cell contamination for all samples was ruled out by negative results (Cq > 40) of real-time 
PCR for granulocyte-specific mRNA (CD15) and lymphocyte-specific mRNA (HLA-DQβ). 
2.2. Expression Level of Putative Reference Genes 
B2M, TBP, UBC, HMBS, PTMA, WIPI2, NCOA, and VAMP were eliminated from further analyses 
during optimization. Exclusion criteria were unacceptable efficiency, low expression level, and the 
presence of non-specific products or primer dimer. Non-specific amplification and primer dimer can 
falsely increase transcript level, especially when intercalating dyes are used to assess real-time PCR.  
Figure 1. Comprehensive gene stability in healthy individuals (A), and in patients with the 
history of myocardial infarction (B). 
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Figure 1 shows the stability of reference genes for platelet transcript level study in healthy 
individuals and in patients with the history of myocardial infarction. Stability is expressed as the 
geometric means of results from four different types of calculation. Candidate reference genes showed 
Cq values between 19 and 34. The amplification efficiency of analyzed genes was as follows: CFL1 
(102%), ACTB (108%), EEF2 (89%), HDGF (81.6%), GAPDH (117.3%), ANAPC5 (81%), GNAS 
(83%), EAR (104%), OAZ1 (96%) (Supplementary Table S2). According to Vandesompele et al., 
minimum three internal control genes should be used for the correct normalization of RT-qPCR data. 
We found GAPDH, GNAS, and ACTB to be the best combination of reference genes for platelet 
transcript level studies in healthy individuals, while HDGF, GNAS, and ACTB are the best for studies 
in patients with the history of myocardial infarction.  
Figure 2. Cyclo-oxygenase 1 (COX-1) transcript level in platelets of patients with the 
history of myocardial infarction. Transcript levels were normalized for OAZ1 (A), or for 
HDGF, GNAS, and ACTB (B). 
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To demonstrate the usefulness of validated candidate reference genes in RT-qPCR, the expression 
level of cyclo-oxygenase 1 (COX-1) gene transcript in platelets of patients with the history of 
myocardial infarction, relative to its expression in a control, was investigated, using the least stable 
gene (OAZ1) and the three most stable reference genes for normalization (Figure 2A,B). COX-1 is 
constitutively expressed in many tissues and is responsible for physiological prostanoid production. 
The mean relative level of COX-1 mRNA in platelets normalized for OAZ1 was 10-fold higher than 
that normalized for HDGF, GNAS, and ACTB. 
3. Discussion 
A few methods have been published for the preparation of platelets free of contaminating 
leukocytes to study mRNA expression. These methods usually need high blood volume, and  
time-consuming preparation steps. In some cases, the absence of leukocytes from the final platelet 
suspension was not, or was not adequately verified. Our method of platelet isolation consists of three 
centrifugations (45 min) and needs only 12 mL of peripheral blood. Such platelet preparations were 
free of granulocytes and lymphocytes, as it was demonstrated by PCR-based methods.  
The RT-qPCR is accepted as the method of choice for the accurate and sensitive quantification of 
transcript levels. The determination of reliable reference genes is an essential step for analyzing 
transcript level using RT-qPCR. Therefore, it is necessary to validate the expression stability of the 
control genes for specific organs, patient groups and/or experimental conditions prior to its use for 
normalization. It is a common practice to use traditional reference genes as internal controls without 
verifying their validity. Based on previous studies we investigated seventeen potentially reference 
genes and on the basis of optimizing studies, nine genes were selected for further studies. The 
stabilities of EEF2, EAR, ACTB, GAPDH, ANAPC5, OAZ1, HDGF, GNAS, and CFL1 genes were 
determined by four different descriptive statistics. 
Many analytical programs have been developed to correct sample-to-sample variation in studies for 
the identification of RGs and the relative quantification of transcript level in a study population. The 
use of multiple reference genes is the most accurate method. BestKeeper, NormFinder and geNorm 
programs are usually preferred, because they are supported by user-friendly software. The major 
weakness of geNorm and the approach developed by Silver et al. [13] are their sensitivity to  
co-regulation. Pairwise comparison apparently tends to select those genes with the highest degree of 
similarity in their expression profile. NormFinder approach does not account for systematic errors 
during sample preparation. The BestKeeper program considers all genes showing a variation in their 
amount of starting material by the factor two or more as unstable, which might limit its use [17].  
It has been reported that three software programs (geNorm, NormFinder and BestKeeper) resulted 
in different ranking order in an attempt to select the most stable reference genes [17,18]; we also 
obtained different results using four different approaches (Supplementary Figures S1 and S2). It is a 
common practice to apply more than one statistical method for the selection of the most stable 
reference genes [18–20]. We employed the RefFinder program, which uses the mean of four statistical 
approaches and ranked the reference genes as a function of their means. Reference genes with the 
lower means were considered more stable than the others. 
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We acknowledge certain limitations of our study. Although a number of measures were introduced 
to keep platelet activation and RNA degradation at a minimum level, the maximum four-hour 
storage/transportation time might be a source of variability in certain conditions. When a study is 
carried out on samples of patients, it is difficult to minimalize the time between blood drawing and 
sample processing. In the case of different disease conditions the effect of storage/transportation on the 
integrity of platelet RNA should be evaluated. Another limitation of the study could be the age 
difference between the group of healthy individuals and patients with coronary artery disease. 
Although, in contrast to some other tissues, in whole blood no age dependence of gene expression was 
observed [21], age difference might introduce a certain level of uncertainty. 
4. Experimental Section 
4.1. Subjects 
Twenty-one patients (age 51–77, 69% male) with the history of myocardial infarction were 
recruited for the study. The diagnosis of myocardial infarction was established at the time of its onset 
according to the criteria of the American College of Cardiology and the European Society of 
Cardiology. Patients were assessed for coronary sclerosis by coronary angiography. All patients 
demonstrated ≥50% stenosis at least in one major coronary artery or in one of their branches. Patients 
were on preventive low dose aspirin therapy. Platelets were also collected from seven apparently 
healthy individuals (age 26–54, 60% male) that did not take any medication.  
4.2. Sample Collection and Preparation 
Twelve mL blood samples were collected in tubes containing acid-citrate-dextrose (Becton 
Dickinson, Schwechat, Austria) The tubes were kept at ambient temperature and transported within 
four hours from the clinical ward to the analytical laboratory where it was immediately processed. On 
reaching the laboratory prostaglandin E1 (100 nmol/L) was added to each tube, and samples were 
centrifuged twice at 150g, for 15 min, at 37 °C. The rotor was allowed to decelerate without using the 
brake. Each time the upper 2/3 of the supernatant was used for the next step. After a third 
centrifugation (2500 rpm, 15 min, 37 °C) the supernatants were completely removed. It is advisable to 
invert the tubes on a sterile tissue for one minute and then wipe out their walls from supernatant’s 
remnants. Centrifugation is an inevitable step for platelet isolation, but it could activate platelets. 
Special care was taken to prevent platelet activation, which might have increased RNA degradation. 
Due to its low pH, anticoagulation by acid-citrate-dextrose, deceleration of centrifuges without brake, 
maintenance of temperature at 37 °C during platelet preparation, and the addition PGE1, an effective 
inhibitor of platelet activation all contributed to keeping platelet activation at a minimum level. It is to 
be noted that in preliminary experiments we did not observe any significant RNA degradation caused 
by up-to four hours storage/transportation and platelet preparation. 
RNA was isolated from the platelet pellet by QIAamp RNA Blood Mini Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. As measured by NanoDrop 2000 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) the RNA concentrations were in 
the range of 2–4 ng/μL. However, as NanoDrop does not measure RNA concentration below 5 ng/μL 
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precisely, we did not assign RNA concentration to the samples and in the case of all samples the same 
volume of RNA preparation was used for cDNA synthesis. The integrity of all RNA samples was 
examined by determining the GAPDH 3':5' signal ratio [5]. The signal ratio was around one (range: 
0.96–1.02) demonstrating the high extent of integrity. SPUD assay was used to check for inhibition in 
each qPCR [22]. PCR analysis of each RNA sample was conducted to ensure the absence of RNA 
contamination from white blood cells [23]. All participants provided informed consent; the study was 
approved by the Ethical Committee of the Medical and Health Science Center, University of Debrecen. 
4.3. Optimizing Primer Concentrations and PCR Efficiency 
Sixteen non-ribosomal candidate reference genes were selected from lists of genes recommended as 
reference genes in two big studies [3,24]. In addition the Alu repeats were also evaluated as candidate 
reference gene [25]. Primers’ lengths were 19–25 nucleotides (TIB MOLBIOL, Berlin, Germany), 
with a theoretical Tm of 59–61 °C. The size of PCR amplicons ranged from 64–150 base pairs. Primers 
were designed to yield products spanning exon-exon boundaries to prevent possible amplification from 
contaminating genomic DNA. PCR products were subsequently resolved in 2% agarose gel to check 
for specific size of the amplicon. For gel electrophoresis, samples were resolved at 80 V in a 2% 
agarose gel with 0.5× Tris-borate/EDTA buffers and stained with ethidium bromide to visualize 
products. The individual efficiency for each primer pair were obtained by using standard curve [26]. 
As indicated by Pestana et al. and the manufacturer’s manual, the efficiency between 50% and 120% 
was accepted [27,28]. 
Our optimization goals were to identify the lowest primer concentration that still yields the lowest 
quantification cycle (Cq), results in maximum fluorescence and generates a single amplicon of correct 
size with predicted melting temperature. In these experiments, all combinations of six concentrations 
(100, 200, 300, 400, 600, 900 nM) of forward and reverse primers for seventeen genes were  
used to generate optimal amplification plots (Supplementary Table S2) [29]. These seventeen  
genes were: GNAS (guanine nucleotide-binding protein, alpha-stimulating), ACTB (actin, beta),  
HDGF (hepatoma-derived growth factor), PTMA (prothymosin, alpha), B2M (beta-2-microglobulin), 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase), HMBS (hydroxymethyl-bilane synthase),  
TBP (TATA box binding protein), UBC (Ubiquitin C), EAR (expressed Alu repeats), OAZ1 (ornithine 
decarboxylase antizyme 1), WIPI2 (WD repeat domain, phosphoinositide interacting 2), NCOA4 (nuclear 
receptor coactivator 4), EEF2 (eukaryotic translation elongation factor 2), VAMP (vesicle-associated 
membrane protein), ANAPC5 (anaphase promoting complex subunit 5), and CFL1 (cofilin 1). 
Primer and probe characteristics are shown in Supplementary Table S2. PCR efficiency (E), 
coefficients of determination (R
2
), and slope values were determined (Supplementary Table S2) using 
five serial 2-fold dilution points; Cq(s) were plotted versus the logarithm of dilution [26]. Minus RT 
controls, that were included for each run, were uniformly negative. PCR specificity for each gene was 
determined by dissociation curve analysis and gel electrophoresis. All primer sets produced a 
symmetrical amplicon peak in melting point analyses. In none of the samples was primer-dimer peak 
and no-template control (NTC) reaction (a negative control without cDNA template) was observed. 
The absence of primer-dimer was also verified by gel electrophoresis.  
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4.4. Reverse Transcription 
RT was carried out under RNase-free conditions. Limited quantities of RNA dictated us to use fixed 
volume (5 μL) of input RNA for each cDNA synthesis [2]. RNA was reverse-transcribed to cDNA in 
20 μL volume in the LightCycler 480 (Roche) by 1st Strand cDNA Synthesis Kit (Roche). For the 
subsequent RT reaction, 0.8 μg (0.04 A260 units) oligio-p [dT]15 primer, 1.6 μg (0.08 A260 units) random 
primer p[dN]6, 20 units AMV reverse transcriptase (Roche) and 50 units RNase inhibitor were added 
and incubated at 25 °C for 10 min and then at 42 °C for 60 min. We performed qPCR on RT triplicates 
instead of qPCR technical replicates [30]. 
4.5. qPCR 
Real-time PCR using LightCycler 480 SYBR Green I Master (Roche) was performed in the 
LightCycler. PCR reaction consisted of 10 μL Master Mix (2× concentration), different concentration 
of primers as established by optimization (Supplementary Table S2), and 5 μL 10-fold diluted reverse 
transcribed total RNA (in a final volume of 20 μL). The following amplification program was used: 
heating for 10 min at 95 °C, 40 cycles of denaturation for 10 s at 95 °C, followed by 60 °C for 30 s  
(55 °C in case of GAPDH) and 72 °C for one second. Subsequently, a dissociation curve (melting 
curve) analysis was applied with one cycle at 95 °C for 15 s, 60 °C for 1 min and 0.5 °C ramp rate to 
95 °C to confirm specific amplification. Cq-values were corrected for PCR efficiencies with the 
equation, Cq100% = CqLogE, (Cq100% = Cq at 100% efficiency). This way, the differences in 
efficiency between different reference genes were compensated. 
4.6. Data Analysis 
During the assessment of a set of RGs, the implemented evaluation method can be a source of bias 
related to the assumptions underlying each approach. In an effort to minimize bias, we tested the 
expression stability of nine selected internal control candidate genes by four different approaches 
found in the literature [4,12–14] by using RefFinder program [15].  
ΔCq approach introduced by Silver et al. compares the relative expression of all pairwise 
combination of genes within each sample [13]. This comparison provides information on which pairs 
show least variability and hence which gene(s) has the most stable expression. The BestKeeper 
software calculates reference gene’s standard deviation (SD) based on raw Cq values regardless of 
sample’s efficiency [14]. NormFinder analysis enables estimation of the overall variation of the 
candidate normalization genes [12]. The combined measure of intra- and intergroup-variation is given 
as a stability value, which is an estimation of the variation in the expression of candidate RGs. The 
basic assumption is that a stable RG should have minimal variation across experimental groups and 
subgroups. Finally, geNorm is a Visual Basic Application for Microsoft Excel, which uses an 
algorithm to calculate M-value, a transcript level stability measure, defined as the mean pairwise 
variation for a given gene compared to the remaining tested genes. Stepwise exclusion of the reference 
gene with the least stable expression finally assigns the two most stable genes [4]. RefFinder is a  
web-based tool to select the most stably expressed mRNAs among a panel of RGs. It integrates 
geNorm, Normfinder, BestKeeper, and the comparative ΔCt method to rank the candidate RGs. It 
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calculates the RG ranking based on each program, then evaluates final ranking by assigning a suitable 
weight to an individual gene and calculates the geometric mean of their weights. 
5. Conclusions 
According to our knowledge, this is the first study on the expression stability of candidate reference 
genes in platelets. This study identified groups of genes suitable for accurate normalization of  
RT-qPCR data in the sample of healthy individuals or patients with the history of myocardial 
infarction. Our results indicate that GAPDH, GNAS, and ACTB are the most stable genes expressed in 
platelets of healthy individuals and HDGF, GNAS, and ACTB were identified as the most stable 
reference genes expressed in platelets from patients with the history of myocardial infarction. The 
results on the expression of COX-1 mRNA clearly demonstrated that the selection of inappropriate RG 
could lead to false assessment of the level of a specific transcript. The selection of appropriate RGs is 
essential for platelet transcript level studies. 
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